• 
  Mylène Guiho, Laurence Lacaze, Damien Bergeat, Emmanuel Allory, Ronan Thibault. Complications nutritionnelles de la chirurgie de l’obésité : prévalence, prévention, traitement. Revue systématique de littérature. Nutrition Clinique et Métabolisme, Elsevier Masson, 2020, 34 (4), pp.263-280. ⟨10.1016/j.nupar.2020.06.002⟩. ⟨hal-03101315⟩
• 
  Ronan Garlantézec, Christopher Heslan, Emilie Tadie, Pierre Tattevin, V. Thibault, et al.. A Lateral Flow Immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers. Emerging Microbes and Infections, 2020, 9 (1), pp.2547-2549. ⟨10.1080/22221751.2020.1852893⟩. ⟨hal-03038403⟩
• 
  Pierre Aucouturier, Vivette D’agati, Pierre Ronco. A Fresh Perspective on Monoclonal Gammopathies of Renal Significance. Kidney International Reports, Elsevier, 2021, Online ahead of print. ⟨10.1016/j.ekir.2021.04.026⟩. ⟨inserm-03261414⟩
• 
  Pablo Tristán-Ramos, Alejandro Rubio-Roldan, Guillermo Peris, Laura Sánchez, Suyapa Amador-Cubero, et al.. The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.5712. ⟨10.1038/s41467-020-19430-4⟩. ⟨inserm-03261333⟩
• 
  P. Sarafidis, C. J. Ferro, E. Morales, A. Ortiz, J. Malyszko, et al.. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, 35 (10), pp.1825. ⟨10.1093/ndt/gfz137⟩. ⟨inserm-03261177⟩
• 
  M. Pugeat, D. Dewailly. Patient requests for improved diagnosis and information in polycystic ovary syndrome. Annales d'Endocrinologie, Elsevier Masson, 2020, 81 (5), pp.473-475. ⟨10.1016/j.ando.2020.10.001⟩. ⟨inserm-03261176⟩
• 
  M. Mura, N. Della Schiava, A. Long, E. N. Chirico, V. Pialoux, et al.. Carotid intraplaque haemorrhage: pathogenesis, histological classification, imaging methods and clinical value. Annals of translational medicine, AME Publishing Company, 2020, 8 (19), pp.1273. ⟨10.21037/atm-20-1974⟩. ⟨inserm-03261174⟩
• 
  N. Mewton, L. Sebbag, T. Bochaton. Other Things Behind the Low Rate of Heart Failure Trial Publication. Journal of the American College of Cardiology, Elsevier, 2020, 76 (14), pp.1716-1717. ⟨10.1016/j.jacc.2020.07.062⟩. ⟨inserm-03261173⟩
• 
  K. Márta, P. Hasan, M. Rodríguez-Prados, M. Paillard, G. Hajnóczky. Pharmacological inhibition of the mitochondrial Ca(2+) uniporter: Relevance for pathophysiology and human therapy. Journal of Molecular and Cellular Cardiology, Elsevier, 2020, 151, pp.135-144. ⟨10.1016/j.yjmcc.2020.09.014⟩. ⟨inserm-03261172⟩
• 
  H. J. Jefferies, S. Lemoine, C. W. Mcintyre. High magnesium dialysate does not improve intradialytic hemodynamics or abrogate myocardial stunning. Hemodialysis International, Wiley, 2020, 24 (4), pp.506-515. ⟨10.1111/hdi.12863⟩. ⟨inserm-03261171⟩
• 
  L. He, P. Souto Barreto, G. Aggarwal, A. D. Nguyen, J. E. Morley, et al.. Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults. Alzheimer's Research and Therapy, BioMed Central, 2020, 12 (1), pp.128. ⟨10.1186/s13195-020-00697-0⟩. ⟨inserm-03261170⟩
• 
  D. Hahn, E. M. Hodson, D. Fouque. Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane database of systematic reviews (Online), 2020, 10 (10), pp.CD001892. ⟨10.1002/14651858.CD001892.pub5⟩. ⟨inserm-03261169⟩
• 
  C. Goettsch, A. Strzelecka-Kiliszek, L. Bessueille, T. Quillard, L. Mechtouff, et al.. TNAP as a therapeutic target for cardiovascular calcification - a discussion of its pleiotropic functions in the body. Cardiovascular Research, Oxford University Press (OUP), 2020, pp.cvaa299. ⟨10.1093/cvr/cvaa299⟩. ⟨inserm-03261168⟩
• 
  D. Fouque, T. A. Ikizler. Editorial: Implementing low protein diets in clinical practice in patients with chronic kidney disease. Nephrology Dialysis Transplantation, Oxford University Press (OUP), 2020, 35 (10), pp.1643-1645. ⟨10.1093/ndt/gfaa242⟩. ⟨inserm-03261166⟩
• 
  V. Flaudias, S. Iceta, O. Zerhouni, R. F. Rodgers, J. Billieux, et al.. COVID-19 pandemic lockdown and problematic eating behaviors in a student population. Journal of Behavioral Addictions, Akademiai Kiado, 2020, 9 (3), pp.826-835. ⟨10.1556/2006.2020.00053⟩. ⟨inserm-03261165⟩
• 
  A. Fikani, P. Lermusiaux, N. Della Schiava, A. Millon. Images in Vascular Medicine: Vasa vasorum associated with endoleak after endovascular repair of abdominal aortic aneurysm. Vascular Medicine, SAGE Publications, 2020, 26 (1), pp.89-90. ⟨10.1177/1358863x20963822⟩. ⟨inserm-03261164⟩
• 
  C. Caussy, L. Johansson. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Pediatric Endocrinology Diabetes and Metabolism, 2020, 3 (4), pp.e00134. ⟨10.1002/edm2.134⟩. ⟨inserm-03261162⟩
• 
  A. Bocquet, A. Briend, J. P. Chouraqui, D. Darmaun, F. Feillet, et al.. The new European regulatory framework for infant and follow-on formulas: Comments from the Committee of Nutrition of the French Society of Pediatrics (CN-SFP). Archives de Pédiatrie, Elsevier, 2020, 27 (7), pp.351--353. ⟨10.1016/j.arcped.2020.09.002⟩. ⟨inserm-03261161⟩
• 
  L. F. M. F. Cardozo, N. A. Borges, B. Lindholm, P. Stenvinkel, P. G. Shiels, et al.. Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease?. Food Research International, Elsevier, 2020, 136, pp.109306. ⟨10.1016/j.foodres.2020.109306⟩. ⟨inserm-03261160⟩
• 
  Fernanda Lima Torres De Aquino, Juliane Pereira Da Silva, Jamylle Nunes de Souza Ferro, Vincent Lagente, Emiliano Barreto. trans-Cinnamic acid, but not p-coumaric acid or methyl cinnamate, induces fibroblast migration through PKA- and p38-MAPK signalling pathways. Journal of Tissue Viability, Elsevier, 2021, ⟨10.1016/j.jtv.2021.05.003⟩. ⟨hal-03247621⟩

39 387